SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Interim Management Statement

21 Oct 2014 07:00

RNS Number : 8018U
Devro PLC
21 October 2014
 



For immediate release 21 October 2014

 

 

Devro plc

(the "Group")

 

Interim Management Statement

Devro plc, one of the world's leading manufacturers of collagen products for the food industry, today issues the following Interim Management Statement for the period from 1 July 2014 to date.

Trading has continued in line with expectations. The business now has had two quarters of growing sales volumes year on year, most notably in China, Japan and Germany, with demand generally showing signs of improvement. Inventory is reducing as expected.

The major investment projects in China and the USA are both proceeding to plan. The replacement of our existing facility in South Carolina addresses the older plant's continued underperformance; an eighteen month programme of transition to the new manufacturing operations has now commenced. Net debt to fund the two projects is rising in line with our expectations. The first phase of the restructuring of our operations in Scotland has been completed on schedule in August and the second phase will conclude at the end of Q1 2015.

The outlook for the full year remains unchanged.

 

ENDS

 

 

For further information, please contact:

 

Devro plc

Peter Page, Chief Executive

Simon Webb, Group Finance Director

 

 

 

Tel No: 020 7182 4960

 

Buchanan

Charles Ryland / Sophie McNulty/

Clare Akhurst

 

 

 

Tel No: 020 7466 5000

 

Notes to Editors

 

FTSE listed Devro is one of the world's leading providers of collagen casings to the food industry supplying a wide range of products and technical support to manufacturers of sausages, salamis, hams and other cooked meats. The Group employs 2,200 staff across the world and produces its casings from five manufacturing sites based in Scotland, Australia, the Czech Republic and the USA. Devro reported sales of £242.7 million and profit before tax (before exceptional items) of £38.8 million for the year ended 31 December 2013. Devro is a constituent of the FTSE4Good Index Series which recognises that the company's performance meets globally recognised corporate responsibility standards.

 

Further information on Devro can be found on the company's website: www.devro.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMMZGKGVGDZM
Date   Source Headline
29th Nov 20225:23 pmRNSDirector/PDMR Shareholding
29th Nov 20225:11 pmRNSForm 8.3 - Devro Plc
29th Nov 20223:28 pmRNSForm 8.3 - Devro plc
29th Nov 20223:24 pmBUSForm 8.3 - DEVRO PLC
29th Nov 20222:34 pmRNSForm 8.3 - DEVRO PLC
29th Nov 202212:47 pmRNSForm 8.3 - Devro plc
29th Nov 202211:23 amGNWForm 8.3 - [Devro plc - 28 11 2022] - (CGWL)
29th Nov 202211:15 amRNSForm 8.3 - Devro Plc
29th Nov 20229:58 amRNSForm 8.5 (EPT/RI) - Devro PLC
29th Nov 20229:45 amRNSForm 8.5 (EPT/RI)-Devro plc
29th Nov 20228:19 amRNSForm 8.3 - Devro PLC Amendment
28th Nov 20224:36 pmRNSForm 8.3 -Devro plc - Amendment
28th Nov 20223:21 pmRNSForm 8.3 - Devro Plc
28th Nov 20223:20 pmRNSForm 8.3 - Devro plc
28th Nov 20223:14 pmRNSForm 8.3 - Devro PLC
28th Nov 20223:03 pmRNSForm 8.3 - Devro plc
28th Nov 20222:59 pmRNSForm 8.3 - Devro PLC
28th Nov 20222:27 pmRNSForm 8.3 - Devro plc
28th Nov 20222:04 pmRNSForm 8.3 - Devro Plc
28th Nov 20221:45 pmRNSForm 8.3 - Devro PLC (closing postion)
28th Nov 20221:27 pmEQSForm 8.3 - The Vanguard Group, Inc.: Devro plc
28th Nov 20221:13 pmRNSForm 8.3 - Devro plc
28th Nov 202212:50 pmRNSForm 8.3 - DEVRO PLC
28th Nov 202212:06 pmRNSForm 8.3 - Devro Plc
28th Nov 202212:01 pmRNSForm 8.3 - Devro Plc
28th Nov 202211:03 amBUSForm 8.3 - Devro plc
28th Nov 202210:51 amRNSForm 8.3 - Devro PLC
28th Nov 202210:39 amGNWForm 8.3 - [DEVRO PLC 25 11 2022] - CGWL
28th Nov 202210:29 amRNSForm 8.5 (EPT/RI) - Devro PLC
28th Nov 20229:18 amRNSForm 8.5 (EPT/NON-RI)-Devro plc
28th Nov 20229:16 amRNSForm 8.5 (EPT/RI)-Devro plc
25th Nov 20222:48 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re Devro plc
25th Nov 202211:35 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - DEVRO PLC - Ordinary Shares
25th Nov 202210:51 amRNSForm 8.3 - Devro PLC
25th Nov 20229:31 amRNSForm 8.3 - Devro plc
25th Nov 20227:01 amRNSTrading Update
25th Nov 20227:00 amRNSRECOMMENDED CASH ACQUISITION
30th Sep 20222:41 pmRNSBLOCK LISTING SIX MONTHLY RETURN
12th Sep 20224:22 pmRNSHolding(s) in Company
2nd Aug 20227:00 amRNSHalf-year Report
29th Jul 20224:35 pmRNSDirector/PDMR Shareholding
27th Jul 20225:38 pmRNSDirector/PDMR Shareholding
11th May 202212:13 pmRNSDirector/PDMR Shareholding
29th Apr 20223:25 pmRNSTotal Voting Rights and Share Capital
28th Apr 20223:51 pmRNSResult of AGM
28th Apr 20227:00 amRNSAGM Trading Update
14th Apr 20222:22 pmRNSDirector/PDMR Shareholding
13th Apr 20226:10 pmRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSHolding(s) in Company
6th Apr 202212:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.